BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Deamination

Deamination is the removal of an amine group from a molecule.In the human body, deamination takes place in the liver. It is the process by which amino acids are broken down. The amino group is removed from the amino acid and converted to ammonia. The rest of the amino acid is made up of mostly carbon and hydrogen, and is recycled or oxidized for energy. Ammonia is toxic to the human system, and enzymes convert it to urea or uric acid by addition of carbon dioxide molecules in the urea cycle. Urea and uric acid can safely diffuse into the blood and then be excreted in urine. (From the Wikpedia article Deamination.)

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Deamination:

Pubmed Logo
Cloning, Protein Sequence Clarification, and Substrate Specificity of a Leucine Dehydrogenase from Bacillus sphaericus ATCC4525.
Although an X-ray model sequence of a leucine dehydrogenase from Bacillus...
16th July, 2008
Department of Chemistry, Southern Methodist University, Dallas, TX, 75275, Appl Biochem Biotechnol. 2008 Jul 15;.
DOI Direct Link
PCR-Based Analysis of Differentially Methylated Regions of GNAS Enables Convenient Diagnostic Testing of Pseudohypoparathyroidism Type Ib.
BACKGROUND: Pseudohypoparathyroidism type Ib (PHPIb) is characterized by...
12th July, 2008
Austrian Research Centers GmbH-ARC, Molecular Diagnostics, Seibersdorf, Clin Chem. 2008 Jul 10;.
DOI Direct Link
Plant histaminase as an investigational drug in splanchnic artery occlusion and reperfusion.
BACKGROUND: Amine oxidases are ubiquitous enzymes involved in the...
12th July, 2008
University of Messina, School of Medicine, Department of Clinical, Expert Opin Investig Drugs. 2008 Aug;17(8):1151-60.
DOI Direct Link
Characterization of Ig gene somatic hypermutation in the absence of activation-induced cytidine deaminase.
Somatic hypermutation (SHM) of Ig genes depends upon the deamination of C...
9th July, 2008
Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal J Immunol. 2008 Jul 15;181(2):1299-306.
Identification of Two Major Ammonia-Releasing Reactions Involved in Secondary Natto Fermentation.
Natto is a traditional Japanese food made from soybeans fermented by...
8th July, 2008
Central Research Institute, Mizkan Group Co. Biosci Biotechnol Biochem. 2008 Jul 7;.

View more research publications.

Deamination Clinical Trials:

Clinical Trials Logo
A Possible Therapeutic Role for Adenosine During Inflammation
Endotoxemia Interventions: Genetic: AMPD1 polymorphism;   Drug: Caffeine infusion;   Drug: placebo

Deamination Patents:

USPTO Logo
US Patent No.Title
7332304 Process and materials for production of glucosamine and N-acetylglucosamine
7351399 Prodrugs for phosphorus-containing compounds
7354591 Poxvirus with targeted infection specificity
7355084 Method for hydrogenating organic compounds by means of Ru/SiO.sub.2 catalysts
7355199 Substituted anthracenes and electronic devices containing the substituted anthracenes

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Deamination scientists - we have details of around 481 individuals working on Deamination .


This page has been viewed 120 times
Recent Search Terms used to find this page: deamination | what is deamination | what is deamination | what is deamination | what is deamination | what is deamination | what is deamination | deamination | deamination | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Deamination across BioPortfolio, or bestselling Deamination books or recently published Deamination books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional